US Patent Issued to HARM REDUCTION THERAPEUTICS on Nov. 4 for "Intranasal pharmaceutical dosage forms comprising naloxone" (British, American, German Inventors)

ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,458,591, issued on Nov. 4, was assigned to HARM REDUCTION THERAPEUTICS INC. (Bethesda, Md.).

"Intranasal pharmaceutical dosage forms comprising naloxone" was invented by John Strang (Denmark Hill, Great Britain), Alexander Oksche (Limburg, Germany), Stephen Harris (Stamford, Conn.), Kevin Smith (Cambridge, Great Britain) and Lucie Helene Jeanne Mottier (Cambridge, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to an intranasal pharmaceutical dosage form comprising a dosing unit comprising naloxone or a pharmaceutically acceptable salt thereof in an amount of equivalent to less than=0.5 mg naloxone HCl dissolved...